Immune cells, such as CD8+ T cells, can naturally remove cancer cells, which implies that certain subclones specifically recognize cancer cells by specific interactions with the T-cell receptor (TCR) and tumor-associated peptides. This evidence concerns the gene CD8A and cancer.